ProCE Banner Activity

CE / CME

Fundamentals III: Improving Shared Decision-making and Addressing Healthcare Disparities

Video

On-demand webcast of expert faculty presentation and case discussion on strategies to improve the care of patients with idiopathic thrombocytopenic purpura (ITP) using shared decision-making and addressing healthcare dispartities.

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners: 0.50 Nursing contact hours, includes 0.50 hour of pharmacotherapy credit

Released: October 18, 2024

Expiration: April 17, 2025

Share

Faculty

Tara Azizi

Tara Azizi, MSN, AGPCNP-BC, CRNP

Division of Classical Hematology
Hospital of The University of Pennsylvania
Philadelphia, Pennsylvania

Lucus W. Enslin

Lucus W. Enslin, MSN, FNP-BC

Nurse Practitioner
Classical Hematology
APP Gen Onc Education and Onboarding Coordinator
Teaching Associate, UW Medicine
Fred Hutchinson Cancer Center
Seattle, Washington

Jennifer Mead

Jennifer Mead, PA-C

Hematology Physician Associate
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sobi, Inc.

Sobi, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Target Audience

This program is intended for nurse practitioners, physician associates, clinical nurse specialists, and advanced degree nurses managing patients with chronic ITP.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Idiopathic thrombocytopenic purpura (ITP).

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Apply enhanced communication strategies to increase patient engagement in shared decision-making and to identify challenges to optimal outcomes, including treatment intolerance, quality-of-life issues, and barriers to clinical trial enrollment

Disclosure

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.

Primary Author

Tara Azizi, MSN, AGPCNP-BC, CRNP

Division of Classical Hematology
Hospital of The University of Pennsylvania
Philadelphia, Pennsylvania

Tara Azizi, MSN, AGPCNP-BC, CRNP, has no relevant financial relationships to disclose.

Lucus W. Enslin, MSN, FNP-BC

Nurse Practitioner
Classical Hematology
APP Gen Onc Education and Onboarding Coordinator
Teaching Associate, UW Medicine
Fred Hutchinson Cancer Center
Seattle, Washington

Lucus W. Enslin, MSN, FNP-BC, has no relevant financial relationships to disclose.

Jennifer Mead, PA-C

Hematology Physician Associate
Massachusetts General Hospital
Boston, Massachusetts

Jennifer Mead, PA-C, has no relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 18, 2024, through April 17, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours, including 0.5 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

LogoDescription automatically generated

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until April 17, 2025. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.